Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Efficacy Evaluation of the Xerf Device for Aesthetic Treatments

NCT: NCT07585591 · COMPLETED

NCT IDNCT07585591
StatusCOMPLETED
Start Date2025-01-20
Completion2025-08-12

Brief Summary

The goal of this clinical study is to evaluate the safety and clinical effectiveness of the XERF noninvasive dual-frequency monopolar radiofrequency device for aesthetic improvement of facial aging, including fine lines and wrinkles, eyebrow lifting, and tightening of lax tissue in the lower face, submental area, and neck in healthy adults. Up to 60 participants may be enrolled across up to five clinical sites in the United States. Participants receive XERF treatments using 6.78 MHz and 2.0 MHz energy; most undergo two sessions approximately four weeks apart (the protocol allows up to three). Standardized photographs are taken at baseline and follow-up visits. Outcomes are assessed approximately 30 and 90 days after the final treatment. Effectiveness is evaluated using investigator-assessed global aesthetic improvement and participant-reported satisfaction, while safety and tolerability are assessed through procedural pain ratings and monitoring of adverse events throughout the study.

Frequently Asked Questions

What is Safety and Efficacy Evaluation of the Xerf Device for Aesthetic Treatments?

Safety and Efficacy Evaluation of the Xerf Device for Aesthetic Treatments is a clinical trial registered under NCT07585591. Current status: COMPLETED.

What is the status of NCT07585591?

The current status of NCT07585591 (Safety and Efficacy Evaluation of the Xerf Device for Aesthetic Treatments) is: COMPLETED.

When did Safety and Efficacy Evaluation of the Xerf Device for Aesthetic Treatments start?

Safety and Efficacy Evaluation of the Xerf Device for Aesthetic Treatments started on 2025-01-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.